European Drug Safety & AI 2026

24–25 Feb 2026 | Barcelona, Spain

ProductUpdated on 13 February 2026

AI-Powered Medical Literature Monitoring for Pharmacovigilance | DrugCard

Head of Marketing at DrugCards

Ukraine

About

AI-powered medical literature monitoring built specifically for pharmacovigilance teams. The platform continuously screens global scientific publications and 2,200+ local journals across 112 countries, identifying potential safety signals and supporting structured case processing in line with regulatory expectations.

Automation removes repetitive manual screening and enables teams to focus on signal detection and risk evaluation. AI-generated article summaries highlight relevant findings instantly, while AI-driven pre-assessment prioritizes safety-relevant references for faster decision-making. Articles can be converted into ICSRs in one click, with automatic translation supporting more than 100 languages to ensure consistent oversight of local sources.

All results are fully traceable and documented, supporting inspection readiness and minimizing compliance risk. DrugCard operates on secure infrastructure compliant with FDA 21 CFR Part 11, ISO/IEC 27001, and SOC 2 Type II standards.

112+ Countries | 2200+ Local Journals | 2 Weeks for new country setup.

Organisation

DrugCards

Estonia

Similar opportunities